Cryoport Belgium
ActiveSummary
Cryoport Belgium has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.5m and a net result of -€5.1m. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 70% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 12-06-2017 Normal situation
- Activity
- Research and development on biotechnology NACE 72101
- Joint committee
- 207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2025
- Establishment unit
- 2.265.818.149 4530 Villers-le-Bouillet, since 12-06-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 04-11-2025
Board and ownership
- Mark SawickiChair
- Stéphane DÉRIDDERDaily manager
- Michaël lweins de WavransDaily manager
- Cryoport Netherlands B.V.100%annual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- -€1.4m
- ▲ 9.7%
- Loss
- €5.1m
- ▲ 15.7%
- Equity
- €12.5m
- Total assets
- €16.2m
- ▲ 90.0%
- Employees on 31-12-2025
- 35
- ▲ 52.2%
- 2025 accounts filed 75 days after the deadline
Score breakdownraises riskLoss of €5.1m, the second in a row (financial year 2025)Last filed accounts filed 75 days late; 1 of the last 3 accounts latelowers riskLiquidity: current ratio 1.64, cash €5.8mSector: Scientific research and development (NACE 72)Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small). It does better than 85% of them on solvency, 83% on liquidity, 11% on profitability and 94% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Resignation: Thibaut Dassesse (daily management delegate)Appointment: Michaël lweins de Wavrans (daily management delegate)
- · Gazette deed Capital & shares
- · Gazette deed Appointments: Thibaut DASSESSE (daily management delegate) and Stéphane DÉRIDDER (daily management delegate)
Comparable companies
These companies have the same main activity as Cryoport Belgium: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €5.3m and €31m, founded between 2013 and 2020.
| Company | Total assets | Gross margin |
|---|---|---|
| Cryoport Belgium Villers-le-Bouillet | €16.2m | -€1.4m |
| ATB THERAPEUTICS Marche-en-Famenne | €10.6m | -€0.5m |
| FYTEKO Anderlecht | €11.7m | -€0.04m |
| Tools4Patient Mont-Saint-Guibert | €23.1m | -€0.4m |
| AUGUSTINE THERAPEUTICS Leuven | €30.9m | -€1.7m |
| DENDROGENIX Liège | €5.3m | -€0.6m |
| Natural Plant based Solutions Bree | €9.4m | -€0.1m |
Key facts about Cryoport Belgium
- What is the company number of Cryoport Belgium?
- The company number of Cryoport Belgium is 0676.713.669. The VAT number is the same number with BE in front: BE 0676.713.669.
- Where is Cryoport Belgium based?
- The registered office is at Rue de la Métallurgie 25, 4530 Villers-le-Bouillet.Company details
- What does Cryoport Belgium do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of Cryoport Belgium?
- The legal form of Cryoport Belgium is Public limited company (NV).
- When was Cryoport Belgium founded?
- Cryoport Belgium was founded on 12-06-2017.
- Is Cryoport Belgium still active?
- Yes, Cryoport Belgium is an active enterprise in the KBO register.
- How many employees does Cryoport Belgium have?
- Cryoport Belgium had an average of 25.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Cryoport Belgium fall under?
- In its 2025 annual accounts, Cryoport Belgium states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
- What is the turnover of Cryoport Belgium?
- The annual accounts for financial year 2025 state no turnover.
- Is Cryoport Belgium profitable?
- In financial year 2025, Cryoport Belgium made a loss of €5.1m.
- Where can I find the annual accounts of Cryoport Belgium?
- Cryoport Belgium filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Cryoport Belgium due?
- Cryoport Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.